Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief ...

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial ...

Chief Executive Officer at Zoetis Inc.

Vaccine will help poultry producers and veterinarians fight rapidly emerging avian metapneumovirus in the United States ...

In a report released yesterday, Daniel Clark from Leerink Partners maintained a Buy rating on Zoetis (ZTS – Research Report), with a price target of $205.00. Discover outperforming stocks and ...

Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $75.4 billion ...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

Zoetis CEO Kristen Peck talks about expanding their line of medications and she says the market for animal care products is growing. Peck also says its arthritis drug for dogs, Librela ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Leerink Partners analyst Daniel Clark reiterated a Buy rating on Zoetis (ZTS – Research Report) on January 13 and set a price target of $215.00. Discover outperforming stocks and invest smarter ...